Skip to main content

Rather Pay $2T per Year or $500B One-Time?

The answer to this question should be a no-brainer:

Is it better to pay trillions of dollars annually in preventable chronic health costs, or to pay a cumulative $500-600 billion or so one-time to cover all student college loan defaults or Great Recession mortgage losses?

Hmmm.  And what's the connection?

We got the massive Dodd-Frank Reform in 2010 to prevent future financial catastrophes, and hopefully Great Recession 2.0--after 1.0 cost private lenders $535B, plus much collateral damage to families & the economy. 

We then got Obama-era regulations, subsequently reversed under Trump, to help prevent student loan defaults.  Now Biden has proposed eliminating all public college/university, historically black college and undergraduate student debt.  This would make a big dent in about $585B in expected student loan defaults. 

So where are the massive federal proposals to head off chronic diseases before they start?  

With total US health spending at about $4T/year, that implies at least $2T/year in preventable annual chronic condition expenditures.  Even if we only reduced those by 25%, we would save $500B/year each year--plenty enough to address many of our non-health problems.  

So the big unanswered question remains:  When are we going to seriously invest in the much bigger issues of preventing inactivity and unhealthy nutrition?

How about both/and: Let's prevent future housing, student loan AND chronic health disasters.  








Comments

Post a Comment

Popular posts from this blog

Is it a “Miracle Drug”?...if it Costs a Fortune and Creates Lifelong Dependency...&...Saggy Faces!?

[It’s been a while since our last blog post.  A lot has happened since– including some “miracles” ! So we’re going to do two posts in a row…] Normally we should all be happy about miracle drugs... shouldn't we ? Yes, there is lots of upside from taking semaglutide (Ozempic, Wegovy), tirzepatide (Montjaro)--and upcoming new, even-more-miraculous drugs TBD:  losing huge amounts of weight quickly, a much lower risk of diabetes–and probably less heart disease and other chronic conditions as well.  But what if the “miracle” requires:   $200-300/week, with a lifetime cost of hundreds of thousands of dollars…  a drug that you can never quit…because if you stop taking it, you gain back all the weight it helped you lose–not to mention the chronic diseases which the drugs kept at bay… and it leaves your face (and the rest of your skin?) sagging …    (plus, it’s so new at such high dosages– who knows what happens after years of use…? ) No doubt, in spit...
4 comments
Read more

It’s Come To This for Many of Our Teens: Radical Surgery and/or a Lifetime of Pharmaceuticals

The American Academy of Pediatrics just came out in favor of powerful prescription drugs (which must be taken lifelong to avoid weight regain & chronic disease) for adolescents--and potentially for pre-teens (ages 8-11)--with moderate to severe obesity. Bari atric surgery (permanently reengineering kids’ gastrointestinal systems) should also be considered for adolescents with severe obesity .  (The Academy also recommends "nutrition support, physical activity, and behavioral therapy"--but as with so many other areas of US chronic disease management, we can see where default treatments are headed: drugs & surgical procedures.) Such radical treatment recommendations created the usual (and temporary and ineffectual) tsunami of news & social media shock and indignation. The decades-long performative reaction to the increasingly bad news on dangerous levels of early obesity–and now 1 in 3 teens with prediabetes, across ethnicities & income levels–is itself sicken...
Post a Comment
Read more

Haven-Not: Silver-Bullet Health "Solution" Misfires

Can you have a better A-Team than this?   Amazon, Chase & Berkshire Hathaway joint venturing  via a new nonprofit, Haven, to finally solve our health care problems!   While I was hopeful when this joint venture was announced several years ago, I was also deeply skeptical.  Rather than addressing the root causes of health costs, such as inactivity and unhealthy nutrition, Haven tried  to "develop new ways to improve access to primary care, simplify insurance coverage and make prescription drugs more affordable"--including by throwing a lot of "big data" tech innovations at these issues. While this approach was pitched as a breakthrough, it was more of a Disease Management 2.0--focusing on more cost-efficient "care," rather than less chronic conditions to begin with.  The latter is the ultimate solution, but requires far more than blue-chip brands plus high-tech to resolve--and a lot more time.   2-3 years of effort just scratches the ...
Post a Comment
Read more